All News

Top news of the day from across the healthcare landscape.

Findings may provide new treatment options for Duchenne muscular dystrophy.

Blood tests show that Americans may deviate from prescription drug regimens.

A synthetic anticoagulant can significantly reduce the risk of drug contamination.

Zika virus may infect glioblastoma stem cells and prevent replication.

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects.

Genome analysis revealed 16 new gene variants that increase the risk of type 2 diabetes and heart disease.

Biosimilars offer the potential to provide patients with less costly alternatives.

Grapefruit juice is not the only juice pharmacists should mention to patients.

Top articles of the week from The American Journal of Pharmacy Benefits.

To control specialty drug costs, many employers have site of care management approaches, while other enact more stringent utilization management procedures.

Data showed a statistically significant increase in adherence to abstinence for the patients with alcohol, cocaine, marijuana and stimulant SUD in those who used Reset, 40.3%, compared to the patients who did not, 17.6%.

In 2015, specialty drug costs increased nearly 10%, the highest rate since 2006.

Brivaracetam (Briviact) is indicated as a monotherapy or adjunctive treatment for patients with partial-onset seizures.

Top news of the week from Specialty Pharmacy Times.

Wnt signaling activation impacts the response to melanoma treatment.

Pharmacists play an important role in keeping communities healthy during flu season. Take the time to listen to patients’ concerns, and be ready with recommendations.

Patients with stage 3 kidney disease cured of hepatitis C virus experienced an improvement in kidney function following treatment.

Company harnesses CRISPR-based gene editing technology as it enters human clinical trials to treat HIV.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Alternative healing, nutrition, physical exercise, and sleep may cure some common ailments instead of medications.

New drug approval highlights the need for value-based payment models for Medicare and Medicaid.

Anti-inflammatory drugs may prevent heart attacks, strokes, and cardiovascular death.

Altered balance of gut microbiota during the first weeks of life may result in type 1 diabetes.

Further clinical trials are required to confirm Aliqopa’s clinical benefit, and the sponsor is conducting these studies.

New biosimilars could play an important role in helping spur competition that can lower health care costs and increase access to important therapies.

Mvasi is indicated to treat adult patients with certain types of colorectal, lung, brain, kidney, and cervical cancers.

Bevacizumab-awwb, a biosimilar to Avastin, approved to treat several cancer types.